Kctd13 deletion reduces synaptic transmission via increased RhoA

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Copy-number variants in the 16p11.2 chromosomal region are associated with neuropsychiatric disorders, including autism spectrum disorders.
• KCTD13 is a gene within the 16p11.2 region implicated in neurodevelopmental phenotypes, but its function in the mammalian brain is not well understood.

Purpose of the Study:

• To investigate the function of the KCTD13 gene in the mammalian brain.
• To determine the role of KCTD13 in synaptic transmission, neurogenesis, and brain size.
• To explore the potential therapeutic implications of KCTD13's function.

Main Methods:

• Gene deletion of Kctd13 in a mouse model.
• Assessment of synaptic transmission.
• Measurement of Ras homolog gene family, member A (RhoA) levels.
• Pharmacological inhibition of RhoA.
• Evaluation of brain size and neurogenesis in mice and zebrafish.

Main Results:

• Deletion of Kctd13 in mice resulted in reduced synaptic transmission.
• Reduced synaptic transmission correlated with increased RhoA levels, and was reversed by RhoA inhibition.
• Kctd13 deletion did not lead to increased brain size or neurogenesis in mice or zebrafish, contrasting with previous knockdown studies.

Conclusions:

• KCTD13 plays a critical role in regulating neuronal function, particularly synaptic transmission.
• Increased RhoA signaling is a key mechanism underlying the effects of KCTD13 deletion on neuronal function.
• KCTD13 is not a significant regulator of brain size or neurogenesis.
• RhoA may represent a potential therapeutic target for neuropsychiatric disorders associated with KCTD13 deletion.